Picture of DRI Healthcare Trust logo

DHT.UN DRI Healthcare Trust Share Price

0.000.00%
ca flag iconLast trade - 00:00
HealthcareBalanced

Momentum

Relative Strength (%)
1m+0.35%
3m+9.97%
6m+33.21%
1yr+84.35%
Volume Change (%)
10d/3m-15.55%
Price vs... (%)
52w High-5.79%
50d MA+1.26%
200d MA+25.89%

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equityn/a
Operating Marginn/a

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS  /

Blurred out image of DRI Healthcare Trust EPS forecast chart

Profile Summary

DRI Healthcare Trust is a Canada-based company, which is engaged in providing financing to advance innovation in the life sciences industry. The Company is involved in pharmaceutical royalty monetization and provides capital to inventors, academic institutions and biopharma companies. It is acquiring approximately 70 royalties on 40-plus drugs, including Eylea, Spinraza, Zytiga, Remicade, Keytruda and Stelara. The Company’s portfolio includes Empaveli, Eylea, Natpara, Omidria, Rydapt, Simponi, Syfovre, Vonjo, Zejula and Zytiga. Its therapeutic areas include influenza, endocrinology, ophthalmology, dermatology, oncology, neurology, autoimmune diseases, heme-onc, lysosomal storage disorder, respiratory diseases, oncology and others. The Company is managed by DRI Capital Inc. Its products are marketed by pharmaceutical companies, including Regeneron, Bayer, Santen; AstraZeneca; Takeda; Galderma Laboratories; Novartis; Biogen; CTI Biopharma; Roche, Novartis, Johnson & Johnson, and others.

Directors

    Last Annual
    Last Interim
    Incorporated
    October 21st, 2020
    Public Since
    February 11th, 2021
    Sector
    Pharmaceuticals
    Industry
    Healthcare
    Exchange
    ca flag iconToronto Stock Exchange
    Shares in Issue
    1

    DHT.UN Share Price Performance

    Upcoming Events for DHT.UN

    Dri Healthcare Trust Annual Shareholders Meeting

    Q1 2024 Dri Healthcare Trust Earnings Call

    Q1 2024 Dri Healthcare Trust Earnings Release

    Dri Healthcare Trust Annual Shareholders Meeting

    Dri Healthcare Trust at RBC Capital Markets Global Healthcare Conference

    Q2 2024 Dri Healthcare Trust Earnings Release

    Similar to DHT.UN

    Picture of Aurora Cannabis logo

    Aurora Cannabis

    ca flag iconToronto Stock Exchange

    Picture of Auxly Cannabis logo

    Auxly Cannabis

    ca flag iconToronto Stock Exchange

    Picture of Bausch Health Companies logo

    Bausch Health Companies

    ca flag iconToronto Stock Exchange

    Picture of Canopy Growth logo

    Canopy Growth

    ca flag iconToronto Stock Exchange

    Picture of Charlotte's Web Holdings logo

    Charlotte's Web Holdings

    ca flag iconToronto Stock Exchange

    FAQ